Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness
Janet B. McGill(Washington University in St. Louis), Clay F. Semenkovich(Washington University in St. Louis), Michael B. Kastan(Duke University), Donald A. McClain(University of Utah), Samuel A. Wickline(Washington University in St. Louis), Víctor G. Dávila‐Román(Washington University in St. Louis), Kevin E. Yarasheski(Washington University in St. Louis), Daniel Ory(Institut de France), Stacy Hurst, Babak Razani(University of Pittsburgh), W. Todd Cade(University of Maryland, Baltimore), Kenneth B. Schechtman(Washington University in St. Louis), Lisa de las Fuentes(Washington University in St. Louis), Richard E. Ostlund(Washington University in St. Louis), Mariko Johnson(Washington University in St. Louis)
Cited by 27
Related Papers
The complexity of p53 modulation: emerging patterns from divergent signals
|Genes & Development|1998|1.3k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|942
Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
|Endocrine Practice|2016|875
Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity
|Cell Metabolism|2016|866
DNA damage induces phosphorylation of the amino terminus of p53
|Genes & Development|1997|824